Detection of p53 point mutations in primary human vulvar cancer by PCR and temperature gradient gel electrophoresis

Gynecologic Oncology

Volumn 64, Issue 1, 1997, Pages 93-98

  Sliutz, G ^a   Schmidt, W ^a   Tempfer, C ^a   Speiser, P ^a   Gitsch, G ^a   Eder, S ^a   Schneeberger, Ch ^a   Kainz, Ch ^a   Zeillinger, R ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; GEL ELECTROPHORESIS; HUMAN; HUMAN TISSUE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TUMOR SUPPRESSOR GENE; VULVA CANCER; VULVECTOMY;

EID: 0031013126     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.4535     Document Type: Article

References (30)

1. 1. Lee, J. M., and Bernstein, A. p53 mutations increase resistance to ionizing radiation, Proc. Natl. Acad. Sci. USA 90, 5742-5746 (1993).
2. 2. Deffie, A., Wu, H., Reinke, V., and Lozano, G. The tumor suppressor p53 regulates its own transcription, Mol. Cell Biol. 13, 3415-3423 (1993).
3. 3. Sutton, G. P., Miser, M. R., Stehman, F. B., Look, K. Y., and Ehrlich, C. E. Trends in operative management of invasive squamous carcinoma of the vulva at Indiana University, Am. J. Obstet. Gynecol. 164, 1472 (1991).
4. 4. Burrell, M. O., Franklin, E. W., Campion, M. J., Crozier, M. A., and Stacy, D. W. The modified radical vulvectomy with groin dissection: An eight-year experience, Am. J. Obstet. Gynecol. 159, 715-722 (1988).
5. 5. Lee, Y. Y., Wilczynski, S. P., Chumakov, A., Chih, D., and Koeffler, H. P. Carcinoma of the vulva: HPV and p53 mutations, Oncogene 9, 1655-1659 (1994).
6. 6. Tervahauta, A. I., Syrjanen, S. M., Vayrynen, M., Saastamoinen, J., and Syrjanen, K. J. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions, Anticancer Res. 13, 1107-1111 (1993).
7. 7. Kucera, H., and Weghaupt, K. The electrosurgical operation of vulvar carcinoma with postoperative irradiation of inguinal lymph nodes, Gynecol Oncol. 29, 158-167 (1988).
8. 8. Pao, W. M., Perez, C. A., Kuske, R. R., Sommers, G. M., Camel, H. M., and Galakatos, A. E. Radiation therapy and conservation surgery for primary and recurrent carcinoma of the vulva: Report of 40 patients and a review of the literature, Int. J. Radiat. Oncol. Biol. Phys. 14, 1123-1132 (1988).
9. 9. Zakut Houri, R., Bienz Tadmor, B., Givol, D., and Oren, M. Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells, EMBO J. 4, 1251-1255 (1985).
10. 10. Lowe, T., Sharefkin, J., Yang, S. Q., and Dieffenbach, C. W. A computer program for selection of oligonucleotide primers for polymerase chain reactions, Nucleic Acids Res. 18, 1757-1761 (1990).
11. 11. Myers, R. M., Sheffield, V. C., and Cox, D. R. PCR technology, Stockton Press, New York (1989).
12. 12. Sheffield, V. C., Cox, D. R., Lerman, L. S., and Myers, R. M. Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes, Proc. Natl. Acad. Sci. USA 86, 232-236 (1989).
13. 13. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis, Cancer Res. 54, 4855-4878 (1994).
14. 14. Borresen, A. L., Hovig, E., Smith-Sorensen, B., Malkin, D., Lystad, S., Andersen, T. I., Nesland, J. M., Isselbacher, K. J., and Friend, S. H. Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations, Proc. Natl. Acad. Sci. USA 88, 8405-8409 (1991).
15. 15. Hamelin, R., Jego, N., Laurent Puig, P., Vidaud, M., and Thomas, G. Efficient screening of p53 mutations by denaturing gradient gel electrophoresis in colorectal tumors, Oncogene 8, 2213-2220 (1993).
16. 16. Crook, T., Wrede, D., and Vousden, K. H. p53 point mutation in HPV negative human cervical carcinoma cell lines, Oncogene 6, 873-875 (1991).
17. 17. Spinardi, L., Mazars, R., and Theillet, C. Protocols for an improved detection of point mutations by SSCP, Nucleic Acids Res. 19, 4009-4009 (1991).
18. 18. Cheng, J., and Haas, M. Sensitivity of detection of heterozygous point mutations in p53 cDNAs by direct PCR sequencing, PCR Methods Appl. 1, 199-201 (1992).
19. 19. Tsuda, H., and Hirohashi, S. Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes, Jpn. J. Cancer Res. 83, 1184-1191 (1992).
20. 20. Iggo, R., Gatter, K., Bartek, J., Lane, D., and Harris, A. L. Increased expression of mutant forms of p53 oncogene in primary lung cancer, Lancet 335, 657-659 (1990).
21. 21. Bookstein, R., Macgrogan, D., Hilsenbeck, S. G., Sharkley, F., and Allred, D. C. p53 is mutated in a subset of advanced-stage prostate cancers, Cancer Res. 53, 3369-3373 (1993).
22. 22. Oka, K., Nakano, T., and Arai, T. p53CM1 expression is not associated with prognosis in uterine cervical carcinoma, Cancer 72, 160-164 (1993).
23. 23. Gitsch, G., Kainz, C., Joura, E., and Breitenecker, G. Mutant p53 product in patients with stage III cervical cancer, Anticancer Res. 12, 2241-2242 (1992).
24. 24. Chen, C. A., Chen, T. M., Wu, C. C., Chang, C. F., and Hsieh, C. Y. Human papillomavirus DNA and p53 status in stage IB bulky cervical cancer, J. Cancer Res. Clin. Oncol. 120, 678-682 (1994).
25. 25. Berchuck, A., Kohler, M. F., Marks, J. R., Wiseman, R., Boyd, J., and Bast, R. C. The p53 tumor suppressor gene frequently is altered in gynecologic cancers, Am. J. Obstet. Gynecol. 170, 246-252 (1994).
26. 26. Mazars, R., Pujol, P., Maudelonde, T., Jeanteur, P., and Theillet, C. p53 mutations in ovarian cancer: a late event? Oncogene 6, 1685-1690 (1991).
27. 27. Pilotti, S., Donghi, R., D'Amato, L., Giarola, M., Longoni, A., Della Torre, G., De Palo, G., Pierotti, M. A., and Rilke, F. HPV detection and p53 alteration in squamous cell verrucous malignancies of the lower genital tract, Diag. Mol. Pathol. 2, 248-256 (1993).
28. 28. Walts, A. E., Koeffler, H. P., and Said, J. W. Localization of p53 protein and human papillomavirus in anogenital squamous lesions: Immunohistochemical and in situ hybridization studies in benign, dysplastic, and malignant epithelia, Hum. Pathol. 24, 1238-1242 (1993).
29. 29. Hietanen, S. H., Kurvinen, K., Syrjanen, K., Grenman, S., Carey, T., McClatchey, K., and Syrjanen, S. Mutation of tumor supressor gene p53 is frequently found in vulvar carcinoma cells, Am. J. Obstet. Gynecol. 173(5), 1477-1482 (1995).
30. 30. Milde-Langosch, K., Albrecht, K., Joram, S., Schlechte, H., Giessing, M., and Loning, T. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva, Int. J. Cancer 63(5), 639-645 (1995).